Pass on the Pink Pill

Addyi (flibanserin), the ineffective and dangerous medication marketed as increasing women’s sexual desire is back again, and its manufacturer is more determined than ever to convince women to buy into its false promises.

We’ve seen this all before. The NWHN opposed Addyi’s 2015 FDA approval, and started our campaign urging women to “Pass on the Pink Pill or Pass Out.” Now that Addyi has reemerged, we’re beginning our campaign once again, ready to combat misinformation with science.

Below you’ll see our most recent information on Addyi. Join us and #PassOnThePinkPill

It’s important to know what’s going into your body, especially if its risks include sudden loss of consciousness and dangerously low blood pressure. Learn the myths and the facts surrounding Addyi here.

Addyi, the female “Viagra,” is back on the market, but is it any better than it was three years ago? According to its continued lack of thorough testing, we say no. Read more about the Addyi testing process.